日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Aumolertinib with carboplatin-pemetrexed versus aumolertinib for nonsmall cell lung cancer with EGFR and concomitant tumor suppressor genes (ACROSS2): An open-label, multicenter, randomized phase 3 study

奥莫替尼联合卡铂-培美曲塞对比奥莫替尼单药治疗EGFR和伴随肿瘤抑制基因的非小细胞肺癌(ACROSS2):一项开放标签、多中心、随机3期研究

Duan, Jian-Chun; Zhong, Jia; Sun, Bo-Yang; Zhao, Wen-Hua; Wu, Lin; Fei, Kai-Lun; Chu, Qian; Guo, Qi-Sen; Song, Qi-Bin; Yu, Yan; Zhu, Da-Xing; Liu, Xin-Yan; Zhao, Jun; Zhan, Zhi-Xiang; Li, Shi; Nie, Lei; Lin, Jie; Peng, Xiao-Dong; Zhong, Dian-Sheng; Zhou, Jin; Li, Li-Hua; Chen, Yun-Fang; Hu, Chen; Mok, Tony; Wang, Zhi-Jie; Wang, Jie

Fuzuloparib with or without apatinib as maintenance therapy in newly diagnosed, advanced ovarian cancer (FZOCUS-1): A multicenter, randomized, double-blind, placebo-controlled phase 3 trial

一项多中心、随机、双盲、安慰剂对照的3期临床试验:在初诊晚期卵巢癌患者中,使用氟哌啶醇联合或不联合阿帕替尼作为维持治疗方案的疗效评价(FZOCUS-1):一项多中心、随机、双盲、安慰剂对照试验

Wu, Lingying; Wang, Jing; Li, Qingshui; Wang, Danbo; Zhang, Cuiying; Tang, Junying; Zhang, Guonan; Hao, Min; Yao, Desheng; Gao, Qinglei; Zhang, Youzhong; An, Ruifang; Yin, Rutie; Wang, Li; Xia, Bairong; Zhou, Qi; Yang, Hongying; Zhu, Jianqing; Jiang, Kui; Chen, Zhengzheng; Wu, Qiang; Duan, Wei; Huang, Yi; Zhang, Hui; Wei, Shuqing; Li, Guiling; Meng, Yuanguang; Wang, Ke; Yang, Xinfeng; Huang, Xianghua; Pan, Lingya; Yu, Jinjin; Lou, Ge; Zhang, Yu; Zhou, Huaijun; Guo, Xiaoqing; Yang, Hong; Cheng, Xiaodong; Li, Xiumin; Wang, Wuliang; Zhao, Hongqin; Li, Yunxia; Yang, Yingjie; Lin, An; Cheng, Wenjun; Chen, Lihong; Xie, Xiaoying; Di, Wen; Hu, Yuanjing; Chen, Mo; Wen, Hongwu; Cai, Liping; Wu, Xiaohua; Lin, Zhongqiu; Wang, Quanren; Yang, Xinfeng; Li, Ning

The evolving landscape of leptomeningeal metastases from NSCLC: an international, contemporary, multicenter cohort study

非小细胞肺癌软脑膜转移的演变格局:一项国际性、当代、多中心队列研究

Zheng, M M; Xia, Y; Pan, K; Sun, F; Tan, A C; Dong, X R; Tu, H Y; Tang, L B; Li, Y S; Yin, K; Borgeaud, M; Singhal, S; Zhu, E; Zhang, J; Nilsson, M; Wu, J; Gibbons, D L; Wakelee, H; Neal, J W; Lee, J; Vaporciyan, A A; Ringsurongkawong, W; Tran, H T; Zhang, R Z; Zhang, T; Zhou, Q; Zhong, W Z; Li, W; Zhang, Y C; Riess, J W; Addeo, A; Heymach, J V; Myall, N; Tan, D; Wu, Y L; Le, X

The consensus molecular subtypes of esophageal squamous cell carcinoma

食管鳞状细胞癌的共识分子亚型

Cui, Heyang; Zhu, Zhongxu; Xu, Enwei; Qi, Lin; Cheng, Yikun; Zhang, Yinghan; Zhang, Ling; Cheng, Matthew Yibo; Yang, Bin; Sun, Ruifang; Zhuang, Xiaofei; Xi, Yanfeng; Yan, Ting; Cheng, Caixia; Ding, Ning; Liu, Huijuan; Wang, Lu; Guo, Min; Guo, Dinghe; Zhang, Haoyu; Peng, Meilan; An, Zhekun; Weng, Yongjia; Wang, Fang; Liu, Meng; Xiong, Ruixin; Yin, Weihua; Song, Bin; Zhang, Weimin; Cheng, Xiaolong; Liu, Zhihua; Zhan, Qimin; Wang, Xin; Cui, Yongping

A novel necroptosis pathway: orchestrated by non-canonical STING-ZBP1 signaling

一种新型坏死性凋亡通路:由非经典STING-ZBP1信号通路调控

Zhu, Xiangyu; Liu, Sijia; Zhang, Long

Deutenzalutamide, a novel androgen receptor inhibitor, after progression on docetaxel and abiraterone in metastatic castration-resistant prostate cancer: results from the randomized phase III HC-1119-04 trial

在转移性去势抵抗性前列腺癌患者接受多西他赛和阿比特龙治疗后出现疾病进展的情况下,新型雄激素受体抑制剂氘代沙鲁胺的疗效:来自随机 III 期 HC-1119-04 试验的结果

Wu, Junlong; Li, Xinghai; Gu, Chengyuan; Hua, Lixin; Liu, Ranlu; Li, Jun; Qiu, Mingxing; Guo, Jianming; Dong, Haiying; Ji, Zhigang; Xie, Liping; Zhu, Shaoxing; Zhang, Xuhui; Chen, Peng; Jiang, Shusuan; Sun, Zhongquan; Xu, Danfeng; Chen, Hui; Shi, Benkang; Wang, Yujie; Pu, Jinxian; Perabo, Frank; Chen, Yuanwei; Ye, Dingwei

mTOR-driven integrin β4-enriched extracellular vesicles from lenvatinib-resistant hepatocellular carcinoma fuel lung metastasis via fibroblast-niche formation

来自耐乐伐替尼肝细胞癌的mTOR驱动的富含整合素β4的细胞外囊泡通过成纤维细胞微环境的形成促进肺转移。

Zou, Tiantian; Wang, Xufeng; Sun, Haoting; Hu, Beiyuan; Li, Jianhua; Guo, Yu; Tian, Zilu; Xu, Hao; Zheng, Yan; Su, Yinghan; Chan, Chak Lam; Zhu, Le; Shen, Keyu; Shen, Xiaotian; Dong, Qiongzhu; Qin, Lun-Xiu

RMzyme: regulations of RNA-modifying enzymes in humans.

RMzyme:人类RNA修饰酶的调控。

Luo Ruihan, Xu Haixia, Zhou Qingbo, Ding Shanli, Qiang Min, Wen Jianguo, Kim Pora, Yang Xiaojuan, Cai Yunshi, Xie Kunlin, Zhu Jiang, Xu Yungang, Lan Tian, Zhou Xiaobo, Wu Hong

Extraocular delivery of bioswitchable tri-miR-22-loaded tetrahedral DNA nanostructures for intraocular neovascular and neurodegenerative repair.

将载有生物可切换三 miR-22 的四面体 DNA 纳米结构进行眼外递送,用于眼内新生血管和神经退行性病变的修复。

Wang Qiong, Wang You, Chen Li, Huang Junyang, Cai Tao, Lin Yi, Liu Jingying, Liu Jinnan, Zhu Jiang, Li Rong, Luo Delun, Ding Xiaoyan

Factor IX-Padua AAV gene therapy in hemophilia B: phases 1/2 and 3 trials

IX因子-Padua AAV基因疗法治疗B型血友病:1/2期和3期试验

Xue, Feng; Ju, Mankai; Zhu, Tienan; Zhou, Zeping; Sun, Jing; Yang, Linhua; Yan, Zhenyu; Zhou, Hu; Du, Xin; Zheng, ChangCheng; Zheng, Jing; Wu, Xia; Du, Zengmin; Jiang, Wei; Yang, Caifeng; Xiao, Xiao; Liu, Wei; Yang, Renchi; Zhang, Lei